Iclusig 15 MG
Ended Awarded
- Contract number
- 36C24525N0120
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,957
Award facts
- Contract value 100% obligated
- $13,956.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract, valued at $13,956.72, is for the supply of the oncology medication ICLUSIG 15 MG to various VA medical facilities across the United States.
The contract was awarded under Takeda's existing General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs, and has an ultimate completion date of October 15, 2024. This delivery order is part of a larger Blanket Purchase Agreement (BPA) between Takeda and the VA National Acquisition Center, which was originally awarded in October 2019 and is valued at over $13 million. The BPA allows for streamlined procurement of ICLUSIG and other specialty oncology medications to support the healthcare needs of veterans.
This contract does not have a set-aside designation, reflecting Takeda's status as a large, foreign-owned business. The VA is the primary funding agency for this contract, which is consistent with the company's established relationship as a key supplier of critical pharmaceuticals to the Department.
Quick answers
Who was awarded contract 36C24525N0120?
36C24525N0120 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 10, 2024.
How much is contract 36C24525N0120 worth?
The government has obligated $13,957 on 36C24525N0120.
Is contract 36C24525N0120 an order under another contract?
Yes. 36C24525N0120 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0120 competed?
The extent of competition for 36C24525N0120 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award